Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05316493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

StatusRecruiting
PhasePhase 2/3
Started2022-06-13
View on ClinicalTrials.gov ↗
To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.

Amendment record

Amended 6 times since 2022-04-04; most recent filed 2026-06-03. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-06-03
Amendment Study Status, Oversight v6
2025-08-06
Amendment Study Status, Oversight v5
2024-07-18
Amendment Study Status v4
2023-05-27
Amendment Study Status v3
2022-06-17
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations, IPDSharing v2
2022-06-05
Amendment Study Status v1
2022-04-04
Original filing
Trial Details
NCT Number NCT05316493
Lead Sponsor Xiaojun Chen
Conditions Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity
Enrollment 172 participants
Start Date 2022-06-13
Primary Completion 2026-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-04